The following outside resources contain helpful information for families and healthcare professionals facing allergy- and immunology-related disorders. Cincinnati Children’s also provides further information on advocacy.
Get updated information about the novel coronavirus (COVID-19) and how it affects patients with allergy / asthma conditions. Read more.
Tale of Two Studies Shows Mixed Progress Against EoE
Cincinnati Children’s Working to Help Kids Suffering From Peanut Allergies
Cincinnati Children’s Receives NIH Grant to Become CoFAR Clinical Research Center
Artificial Intelligence Assists Expanded Hunt for Cells Driving Eosinophilic Esophagitis
Cincinnati Children’s Joins Consortium of Food Allergy Research
FARE Releases Educational Resources for Those Without the Disease of Food Allergy
Statement: NIH Trial Data Underpins FDA Approval of Omalizumab for Food Allergy
Researchers Produce Annotated Molecular Map of Eosinophilic Esophagitis
How Common are Penicillin Allergies? CDC Says "True Penicillin Allergy" is Rare.
Why Your Child Most Likely Does Not Have A Penicillin Allergy
Eosinophilic Esophagitis Risk Linked to Medications in Pregnancy, Infancy
Profiling the Liver’s Frontline Defender
Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE) "This is an exciting step forward and shows the impact that our collective voices and partnership can have. I am optimistic about the outcome." ~Marc Rothenberg
TSLP Inhibitors Emerge as Potential Therapy for Eosinophilic Esophagitis
Arnold Strauss Research Fellowship: Mario Ynga Durand, MD, PhD
After 1 Year, Weekly Doses of Dupilumab Most Effective at Managing Eosinophilic Esophagitis
The Lancet Gastroenterology & Hepatology interviewed Marc Rothenberg, MD, PhD about the recent findings regarding benralizumab for eosinophilic gastritis.
Wider Search Needed to Better Treat Eosinophilic Food Allergy
Pew Latin American Fellow: Mario Alberto Ynga Durand
FARE Announces Formation of Scientific Advisory Council
Marc Rothenberg Earns UC College of Medicine’s Top Award
Curiosity Drives Drake Medal Winner Marc Rothenberg, MD, PhD
Consult on Antibiotic Associated Rashes
Eliminating Just One Food Trigger Can Improve Life for People With EoE
Bringing Dietary Therapy for Eosinophilic Oesophagitis Under Scientific Scrutiny
Milk Elimination Diet Shows Promise as First-Line Therapy for Eosinophilic Esophagitis
CEGIR’s Marc Rothenberg Receives AAAAI 2023 Distinguished Scientist Award
2022 Research Highlight Videos: Division of Allergy and Immunology at Cincinnati Children's
Characterizing Eosinophilic Duodenitis
Clinical Trial Research Participation: a few words from Marc Rothenberg, MD, PhD
Biological Agent Successfully Treats Eosinophilic Esophagitis
Dupilumab improves eosinophilic esophagitis outcomes through 52 weeks
Tetsuo Shoda, MD, PhD Receives Trustee Award for his outstanding proposal entitled “Role of RhoA GTPase Pathway in Eosinophilic Esophagitis”.
Eosinophilic Gastrointestinal Disorders (EGID): Clinical Trial Update In View of Recent 2022 Data
Update on the MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
Cincinnati Children's Hospital's Rothenberg named to National Academy of Medicine
Marc Rothenberg, MD, PhD Elected to National Academy of Medicine
Food Allergies Oral Immunotherapy Treatment Teal Pumpkin Campaign and More
2023 AAAAI Honorary Award Recipient of Distinguished Scientist Award: Marc Rothenberg, MD, PhD
First FDA-Approved Treatment for Eosinophilic Esophagitis Has Roots in NIAID-Funded Research
Marc Rothenberg, MD - Stephen I. Wasserman Lecture: Journey to the First FDA-Approved Drug
Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's
Vitamin D Supplementation Alleviates IL-13–Induced Esophageal Inflammation
Patients with eosinophilic esophagitis symptoms may benefit from gastric emptying studies
Marc Rothenberg selected as the 2023 recipient of the AAAAI Distinguished Scientist Award
New Treatment Gives Hope to Those with Eosinophilic Esophagitis
Journal Devotes Cover to Eosinophilic Esophagitis Research
CEGIR: Online Communities Illuminate Needs and Goals of Patients with Eosinophilic Esophagitis
Development of Outcome Metrics Leads to First FDA-Approved Treatment for Eosinophilic Esophagitis
Young and Healthy Podcast: 2022 Formula Shortage: Update for Families
Why Your Child Most Likely Does Not Have A Penicillin Allergy
NORD Applauds House Passage of H.R. 7667, the Food and Drug Amendments of 2022
FDA Approves Dupilumab for Children With Eczema Aged 6 Months to 5 Years
Q&A: Dupilumab Approved for EoE, Plus Hope for More Therapies
Q&A: FDA approval of dupilumab for eosinophilic esophagitis a ‘victory for rare diseases’
FDA Approval of Dupilumab Celebration at Cincinnati Children's
First Treatment for Eosinophilic Esophagitis Wins FDA Approval
FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder
One Family’s Story about Penicillin Allergy Testing
Scientists Making Progress Against a Severe Form of Food Allergy
What to Expect from Your Nasal Endoscopy Video
Highlights of Eosinophilic Disease-Related Research (May 2021-2022)
Message on National Eosinophilic Awareness Week: CEGIR Administrative Director
Message on National Eosinophilic Awareness Week: CEGIR Principal Investigator
2022 Scholar Day Presentation by Marc Rothenberg, MD, PhD
Eosinophilic Esophagitis (NORD) Video
Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers
Young and Healthy Podcast: Plant-based Milk Alternatives and Kids
2022 Eleventh Annual Department of Internal Medicine Research Symposium
Congratulations to the Internal Medicine Allergy Fellows whose research were recognized at the 2022 Eleventh Annual Department of Internal Medicine Research Symposium!
March 24
New Federal Spending Bill Also Helps Food Allergic School Children
March 22
Earlier and Longer Pollen Seasons Due to Climate Change Expected to Impact Allergic Diseases
March 16
Climate Change Cited as Cause of Recent Increases in Asthma Allergy Prevalence
February 13
Building a Community to Change the Outcome Together Through Research
January
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions
Since the World Allergy Organization (WAO) Diagnosis and Rationale against Cow's Milk Allergy (DRACMA) Guidelines were published 10 years ago, new evidence has accumulated about the diagnosis, therapy, and specific immunotherapy for cow's milk allergy (CMA). For this reason, WAO has felt the need to update the guidelines. Thank you to our local colleague, Amal H. Assa'ad, MD, for her dedicated work as part of the WAO DRACMA guideline group!
January 26
Community Access Funding to Focus on Increasing Diverse Engagement in Food Allergy Research
January 26
Molecular Analysis Suggests Eosinophilic Colitis is a Unique Disease
January 24
Cincinnati Magazine Top Doctors of 2022
Thank you to all our physicians for the great work that they do every day and congratulations to Drs. Sandy Durrani, Yasmin Hassoun, Michelle Lierl, Kimberly Risma, and Marc Rothenberg for being recognized as Top Doctors 2022 in Allergy/Immunology by Cincinnati Magazine!
January
Allergic to Penicillin? Don't Make Rash Judgments
January 7
Preparing for Progress on Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis
Remote immune processes revealed by immune-derived circulating cell-free DNA
Marc Rothenberg, MD, PhD and his team are collaborating with Israeli scientists to develop non-invasive biomarkers for eosinophilic esophagitis (EoE); in this publication, they describe recent findings in their pursuit to develop an EoE blood test.Two Genes Associated with Familial EoE
2021 STAT Wunderkind Award to Tetsuo Shoda
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Video
Artificial Intelligence Holds the Key to Diagnosing Rare Esophageal Food Allergy Disease
“It is exciting to see this continual positive data, especially knowing that the foundation for this therapy was derived from our long term research focus deciphering the role of type 2 immunity (IL-13) in Eosinophilic Esophagitis and other related diseases." ~Marc Rothenberg, MD, PhD
Cincinnati Children’s Launching Collaboration with Technion-Israel Institute of Technology
Neonatal Antibiotics Disrupt Esophageal Microbiota, May Increase Risk of EoE
Groundbreaking partnership combines Israeli technological prowess with pediatric medicine
Discovery of Rapid-Response Signaling Platform Suggests New Path for Blocking Allergic Inflammation
Melanie Uses Pageant Platform to Share Her Story and Build Eosinophilic Esophagitis Awareness
Congratulations to Amal H. Assa'ad, MD for one of her July publications being among the most shared science at Cincinnati Children's!
Summer Undergraduate Research Fellowship Awardee
Congratulations to Andrea for winning 2nd place for her Summer Undergraduate Research Fellowship (SURF) presentation! This presentation was based on the research that Andrea conducted in the Rothenberg CURED Lab through the SURF Medical Exploration program. Under the mentorship of Julia Dunn, PhD and Marc Rothenberg, MD, PhD, Andrea investigated gene expression patterns of eosinophils in patients with eosinophilic esophagitis.
Division NIH LRP Awardees
Congratulations to Assistant Professor Ashley L. Devonshire, MD, MPH and third-year clinical fellow Simin Zhang, MD, for being recognized for their excellence with awards from a Loan Repayment Program (LRP) of the National Institutes of Health! The NIH LRPs are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The escalating costs of advanced education and training in medicine and clinical specialties are forcing some scientists to abandon their research careers for higher-paying private industry or private practice careers. The LRPs counteract that financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research and are highly competitive. Drs. Devonshire and Zhang continue the strong showing of the division in having NIH LRP recipients, including prior NIH LRP awards to Drs. Michael G. Sherenian, MD, MS, Steve P. Proper, DO, PhD, and Joseph Sherrill, PhD. Since tomorrow's medical breakthroughs will be made by investigators starting in their research careers today, the LRPs represent an important investment by NIH in the future of health discovery and the wellbeing of the Nation and represent recognition of an investigator's potential. Dr. Devonshire is currently researching food allergy and food allergy risk in infants. Dr. Zhang is currently researching mast cell involvement and functions in eosinophilic esophagitis under the mentorship of Marc Rothenberg, MD, PhD and J. Pablo Abonia, MD.
Irritable Bowel Syndrome and the Food Allergy Connection
“Common gastrointestinal ailments, such as irritable bowel syndrome (IBS) and functional abdominal pain, may instead be food-induced allergic disorders,” says our Cincinnati Children's Center for Pediatric Genomics awardee Marc Rothenberg, MD, PhD in the NY Times.
Less Restrictive Diet for Adult EoE with Milk Trigger: Some Adults with EoE Allergy Can Just Cut Milk, Instead of 6 Foods
Care Providers Read Patient Comments from Experience Surveys: Yasmin Hassoun
At Cincinnati Children's, our caregivers go above and beyond each day to give patients the best experience possible. Hear how they, including Yasmin Hassoun, MD (Allergy/Immunology), react to meaningful words straight from their patient families.
April 29
Decoding the Mysteries of Postural Orthostatic Tachycardia Syndrome
This is encouraging news for all of our patients and families effected by the combination of postural orthostatic tachycardia syndrome (POTS) and eosinophilic gastrointestinal disorders (EGIDs).
April 21
Amoxicillin-associated Rash
April 1
Congratulations to two of our Cincinnati Children's and University of Cincinnati Allergy / Immunology fellows for being recognized with first and second place in clinical research at the 10th Annual Department of Internal Medicine Research Symposium. Simin Zhang, MD was awarded 1st for her project “Clinical Significance of Mast Cell Density in GI Biopsies in Patients Presenting for Evaluation of GI Mast Cell Disorders”, and David Adams, PhD was awarded 2nd place for his project: "Multifactorial Regulation of Axl Expression".
March
Who We Are: Rare Diseases Clinical Research Network Video
February 22
Cincinnati Children’s Team and Faculty Awards
Allergy Nursing Team recognized as the “2020 Top Performing Small Division for Outstanding Nursing Patient Family Experience (PFE)”! This honor was awarded based on a review of the annual experience survey scores and positive comments, which highlight the exceptional feedback the team routinely receives from the patients and families. The team was recognized in a virtual awards ceremony held on Monday, February 22nd. Thank you for all you do, for making a difference in the lives of so many families and for promoting a positive experience at Cincinnati Children’s!
Vincent Mukkada, MD received the “2020 Top Pediatric Provider Award” at Cincinnati Children’s! This is an amazing, well-deserved accomplishment, reflecting not only his outstanding clinical care, but also a great team at large with the Division of Gastroenterology, Hepatology and Nutrition and the Cincinnati Center for Eosinophilic Disorders.
Kimberly Risma, MD, PhD received the “2020 Clinical Care Achievement Award”! Dr. Risma is an extraordinary clinician whose innovation has led to the creation of the Drug Allergy Program launched in 2019. She is also having a leading impact in promoting the next generation of physicians in the allergy and immunology field. This award is most deserving and demonstrates appreciation for her immense dedication, talents and contributions.
February 11
2020 Research Highlights: Division of Allergy and Immunology
February 11
RDCRN Announces New 2021 Network Steering Committee Leadership
We are pleased to announce that Marc Rothenberg, MD, PhD has been elected as co-chair of the Rare Diseases Clinical Research Network (RDCRN, www.rarediseasesnetwork.org) Steering Committee. Dr. Rothenberg will join Dr. Jennifer Puck and Dr. Andrea Gropman in leading the RDCRN Steering Committee.
January 21
Cincinnati Children’s to House Food Allergy Biobank and Biomarker Discovery Center
January 21
FARE Announces Key Partnerships in Crusade to Advance Food Allergy Research
January 13
EoE Research Selected as ‘Editor’s Choice’ in JACI
January 6
How Experts at Cincinnati Children's Hospital Medical Center are Combatting Allergic Reactions
The Ghory Lecture is an annual event presented by the Division of Allergy and Immunology at Cincinnati Children’s and the Cincinnati Asthma and Allergy Society. It began in 1991 and was named in honor of Joseph E. Ghory, MD.
Dr. Joseph Ghory was born and raised in Cincinnati, Ohio. He received his M.D. from the Ohio State University College of Medicine in 1939. After completing a pediatric residency at the Children's Hospital in Cincinnati, he practiced general pediatrics in Cincinnati for 17 years.
He was devoted to teaching and was instrumental in establishing the pediatric residency training program at Good Samaritan Hospital, where he served as the first director of pediatric education. He was elected president of the Cincinnati Pediatric Society, the Children’s Hospital Medical Staff and the Academy of Medicine of Cincinnati. Impressed by the large number of children with allergic diseases, he sought additional training in allergy and became the first board-certified pediatric allergist in Cincinnati in 1960. Together with Dr. Leonard Bernstein, Dr. Ghory established the Allergy Fellowship at the University of Cincinnati and the Children’s Hospital.
Dr. Ghory’s special interest and vision was the long-term care and rehabilitation of children with intractable asthma, using a community approach with involvement of the family and a limited hospital stay. He thus became director of the Convalescent Hospital for Children in Cincinnati, organized and presided over the national Association of Convalescent Homes and Hospitals for Asthmatic Children and was chairman of the Rehabilitation Committee of the American Academy of Allergy and Immunology.
Dr. Ghory’s greatest pride was his family, and his legacy lives on in two of his daughters, Ann Ghory, M.D. and Patricia Ghory, M.D., who are practicing allergists in the Cincinnati area, and now in three of his grandchildren, who are now our young practicing and future allergists.
2024 – Steve Holland
2023 – Jonathan Bernstein
2022 – Marc Rothenberg
2021 – Aikaterini Anagnostou
2020 – Sandy Durrani and Justin Schwartz
2019 – William W. Busse
2018 – Seema Aceves
2017 – Elizabeth Phillips
2016 – Carina Venter
2015 – Kara Shah
2014 – Linda Cox
2013 – Kimberly Risma
2012 – David Fleischer
2011 – Amal Assa’ad
2009 – Marc Rothenberg
2008 – Scott Sicherer
2007 – Carolyn Kercsmar
2006 – Jim Gern
2005 – Sally Wenzel
2004 – Anne-Marie Irani
2003 – Donald Leung
2002 – Fernando Martinez
2001 – Marianne Frieri
2000 – Wesley Burks
1999 – Alan Kaplan
1998 – Bruce Bochner
1997 – Robert Lemanske
1996 – Peter Creticos
1995 – Michael Blais
1994 – Paul Greenberger
1993 – Elliot Ellis
1992 – Louise Marker
1991 – Sami Bahna
Learn more about research efforts on eosinophilic conditions. The Research Horizons blog provides news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children’s.
Read More
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
